SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba shares are under pressure as investors weigh a major $10.2 billion share offering to fund AI expansion, a move heavily criticized by veteran investor Michael Burry over dilution concerns.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is facing intense backlash from retail investors after announcing a large at-the-market equity offering after-hours on a Friday, sparking widespread fears of share dilution. While some traders are aggressively shorting the stock on dilution concerns, others maintain a bullish outlook, viewing the capital raise as a necessary move to fund capacity expansion amid booming demand for AI infrastructure.

TOSHI

TOSHI is trending as the community speculates on a potential short squeeze, citing renewed social activity and optimistic hopes for upcoming exchange listings or catalysts. Holders are actively debating whether current price action signals a bottom, with many continuing to accumulate in anticipation of a significant breakout.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is surging following the disclosure of an expanded partnership with Google, which includes a multibillion-dollar custom chip agreement and stock warrants tied to future revenue targets. Retail investors are buzzing about the stock's long-term potential as a data infrastructure leader, though sentiment remains split between bullish excitement over the deal and bearish caution regarding potential future dilution.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following segments: Walmart U.S., Walmart International, and Sam's Club U.S. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club U.S. segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is facing significant downward pressure following its recent earnings report, where slower-than-expected sales growth sparked widespread concern among retail traders regarding consumer resilience. The community is actively debating whether this double-digit sell-off represents a compelling buying opportunity for a long-term staple or a sign of deeper economic weakness.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is trading lower ahead of upcoming earnings, with investors expressing significant frustration over persistent share price manipulation and stagnant performance despite recent positive fundamental developments. While the community is debating whether the current weakness is a shakeout ahead of a potential buyout or a result of underlying growth concerns, many remain focused on the company's rare disease franchise as a key long-term catalyst.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trending as investors anticipate the upcoming 80th clinical event from the REGAL Phase 3 trial, fueling high-stakes buyout speculation and heavy short-covering momentum. The community is actively debating the trial's impact, the potential for a curative AML treatment, and the strategic interest from major pharmaceutical players.

iShares Ethereum Trust (The) - iShares Ethereum Trust ETF

iShares Ethereum Trust ETF

Investors are closely watching iShares Ethereum Trust (ETHA) as the Ethereum ecosystem faces volatility and ongoing debates over infrastructure development. Retail sentiment remains bullish, with many market participants focusing on potential institutional inflows and long-term price appreciation potential despite mixed commentary from industry figures.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is facing significant downward pressure as market participants debate whether the recent price decline represents a manipulation-driven "shakeout" or a fundamental shift in sentiment. Community members are actively discussing the stock's technical support levels and massive insider buying, with many expecting a rebound driven by high demand for CPU capacity and upcoming AI-sector catalysts.

ETF Opportunities Trust - T-REX 2X Long SNDK Daily Target ETF

The community is actively trading the T-REX 2X Long SNDK Daily Target ETF (SNDU) as a leveraged play on the price action of SanDisk (SNDK), with many sharing strategies for buying dips and managing volatility ahead of corporate events. Traders are frequently coordinating buy and sell orders in an attempt to influence market momentum and capitalize on the ETF's daily performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here's What Matters for Investors

Key PointsThis disposition involved 3,500 shares at $38.42 per share, totaling $134,470...

An AtriCure Director Sold $905,000 in Stock. Here's How to Read It

Key PointsKaren Prange disposed of 3,564 shares for a total transaction value of approximately $138,283 on August 5...

Director At AtriCure Sells $134K Of Stock

It was reported on August 7, that Maggie Yuen, Director at AtriCure (NASDAQ:ATRC) executed a significant insider sell, according to an SEC filing.
What Happened: According to a Form 4 filing with the U.S. Securities andread more...

Are Options Traders Betting on a Big Move in AtriCure Stock?

Investors need to pay close attention to ATRC stock based on the movements in the options market lately. 

AtriCure to Participate at Upcoming Investor Conferences

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in two upcoming investor conferences. AtriCures...

AtriCure (ATRC) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for AtriCure (ATRC) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

AtriCure Reports Q2 2026 Results: Full Earnings Call Transcript

AtriCure (NASDAQ:ATRC) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below.
This transcript is brought to you by Benzingaread more...

AtriCure (ATRC) Q2 Earnings and Revenues Top Estimates

AtriCure (ATRC) delivered earnings and revenue surprises of +500.00% and +1.39%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

AtriCure Reports Second Quarter 2026 Financial Results

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced second quarter 2026 financial results. Our team delivered healthy growth and a...

AtriCure to Announce Second Quarter 2026 Financial Results

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its second quarter 2026 financial results on Thursday, July 23...

$ATRC Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.18 up 238.46% YoY
• Reported revenue of $153.6M up 12.83% YoY
• AtriCure projects full year 2026 revenue of approximately $602 million to $610 million, adjusted EBITDA of $85 million to $89 million, and adjusted earnings per share of $0.24 to $0.32.

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.

Atricure Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ATRC Atricure Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest ATRC News